Shareholders Equity: The sum of preferred and common equity items.
Anika Therapeutics Inc. (ANIK) had Shareholders Equity of $143.47M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$30.61M |
|
$0.29M |
|
$11.44M |
|
$19.18M |
|
$29.97M |
|
$0.65M |
|
$0.12M |
|
$0.76M |
|
$0.76M |
|
$1.80M |
|
$1.80M |
|
$0.29M |
|
$1.80M |
|
$0.65M |
|
-- |
|
14.27M |
|
14.67M |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$103.36M |
|
$40.32M |
|
$86.91M |
|
$190.27M |
|
$21.91M |
|
-- |
|
$24.90M |
|
$46.80M |
|
$143.47M |
|
$133.76M |
|
|
Shareholders Equity |
$143.47M |
-- |
|
| Cash Flow Statement Financials | |
$11.19M |
|
$-0.40M |
|
$-10.55M |
|
$57.16M |
|
$57.48M |
|
$0.32M |
|
$10.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|